Improved use of .beta.2 bronchodilator drugs

Details Improved use of .beta.2 bronchodilator drugs Improved use of .beta.2 bronchodilator drugs

A - Human Necessities

61

K

A61K 31/445 (2006.01) A61K 31/135 (2006.01) A61K 31/17 (2006.01) A61K 31/235 (2006.01) A61K 31/27 (2006.01) A61K 31/44 (2006.01) A61K 31/47 (2006.01) A61K 31/52 (2006.01)

Patent

CA 2065051

Improved use of selective .beta.2 sympathomimetic bronchodilator drugs in the therapy of obstructive or inflammatory airways disease, e.g. asthma, comprises use in enantiomeric rather than conventional racemic form. The improved use reduces occurrence of side effect, e.g. exacerbation of basal disease status or compromise or deterioration of lung function.

Affiliated with

Also associated with

Rating

Improved use of .beta.2 bronchodilator drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved use of .beta.2 bronchodilator drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved use of .beta.2 bronchodilator drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2031554